Efficacy and safety of degarelix in Korean patients with prostate cancer requiring androgen deprivation therapy: Open-label multicenter phase III study

PURPOSE: To assess the noninferiority, efficacy, and safety of degarelix in achieving and maintaining testosterone at castrate levels (≤0.5 ng/mL) in Korean patients (CS42) versus non-Asian patients with prostate cancer (PCa). METHODS: A Phase III, open-label, multicenter, single-arm trial was condu...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Prostate Int
Main Authors: You, Dalsan, Chung, Byung Ha, Lee, Sang Eun, Kim, Choung-Soo
Formato: Artigo
Idioma:Inglês
Publicado: Asian Pacific Prostate Society 2015
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4494635/
https://ncbi.nlm.nih.gov/pubmed/26157762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prnil.2015.02.005
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares